Skip to main content
Article
Phase I and Immunomodulatory Study of a Muramyl Peptide, Muramyl Tripeptide Phosphatidylethanolamine
Cancer Research (1990)
  • Walter J. Urba, National Institutes of Health
  • Lynn C. Hartmann, National Institutes of Health
  • Dan L. Longo, National Institutes of Health
  • Ronald G. Steis, National Institutes of Health
  • John W. Smith, National Institutes of Health
  • Igal Kedar, National Institutes of Health
  • Stephen Creekmore, National Institutes of Health
  • Mario Sznol, National Institutes of Health
  • Kevin Conlon, National Institutes of Health
  • William C. Kopp, National Institutes of Health
  • Christoph Huber, University of Innsbruck
  • Manfred Herold, University of Innsbruck
  • W. Gregory Alvord, National Institutes of Health
  • Sandra Snow, Memorial Hospital of South Bend
  • Jeffrey W. Clark, National Institutes of Health
Publication Date
May 15, 1990
Citation Information
Walter J. Urba, Lynn C. Hartmann, Dan L. Longo, Ronald G. Steis, et al.. "Phase I and Immunomodulatory Study of a Muramyl Peptide, Muramyl Tripeptide Phosphatidylethanolamine" Cancer Research Vol. 50 Iss. 10 (1990) p. 2979 - 2986
Available at: http://works.bepress.com/walter-urba/68/